MyMD Pharmaceuticals is a clinical stage pharmaceutical company. Co. is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease and is being developed to treat age-related illnesses. Supera-CBD is a synthetic analog of cannabidiol being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme type B. We show 14 historical shares outstanding datapoints in our MYMD shares outstanding history coverage, used to compute MYMD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing MYMD market cap history over the course of time is important for investors
interested in comparing MYMD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of MYMD versus a peer is one thing; comparing
MYMD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like MYMD can fluctuate over the course of history.
With this page we aim to empower investors researching MYMD by allowing them to research the MYMD market cap history. |
Free MYMD Email Alerts:
Video: The Importance of Market Cap
